NCT04019548 - Assessment of Swallowing Function and Quality of Life in Oropharyngeal Cancer Patients Treated by Chemo-radiotherapy | Biotech Hunter

Enrollment

110

Participants

Timeline

Start Date

December 16, 2019

Primary Completion Date

November 1, 2027

Study Completion Date

May 1, 2030

Conditions

Oropharyngeal Cancer

Interventions

DEVICE

Percutaneous Endoscopic Gastrotomy tube placement

placement of the PEG tube depends on arm

DRUG

Cisplatin injection

"Two therapeutic regimen allowed:~* Days 1 and 22 : cisplatin 100mg/m2 IV~* Days 1,8,15,22,29,36: weekly cisplatin 40 mg/m2 IV"

RADIATION

Radiotherapy

Simultaneous integrated boost (SIB) intensity modulated radiotherapy (IMRT). The median dose prescription will be 32 x 2.16 Gy to the high risk PTV and 32 x 1.75 Gy to the elective PTV.

Trial Locations (2)

1000

NOT_YET_RECRUITING

CHU Saint Pierre, Brussels

RECRUITING

Institut Jules Bordet, Brussels